Aspira Pathlab & Diagnostics Limited (BOM:540788)

Market Cap	1.32B +107.4%
Revenue (ttm)	249.82M +13.6%
Net Income	513.00K -97.5%
EPS	0.05 -97.5%
Shares Out	10.29M
PE Ratio	2,569.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	546
Open	131.00
Previous Close	133.29
Day's Range	130.65 - 131.00
52-Week Range	49.00 - 135.88
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	May 23, 2026

About BOM:540788

Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was ...

• Industry: Medical Laboratories
• Founded: 1973
• Employees: 141
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540788

Financial Performance

In fiscal year 2026, BOM:540788's revenue was 249.82 million, an increase of 13.56% compared to the previous year's 219.99 million. Earnings were 513,000, a decrease of -97.46%.